Testimonials: Doctor
Peter H. Langsjoen, MD, FACC
It is my strong feeling that this ubiquinol product is a major breakthrough. I have carefully reviewed our experience with ubiquinol beginning last summer when we initially evaluated this product in healthy subjects. I will briefly summarize this as follows:
In September 2006, a healthy 52 years old woman on 100 mg three times per day of CoQ10 oxidized formulation in soybean oil, plasma CoQ10 level was 2.5 µg/ml with 0.7% oxidized and the ratio of CoQ10 to cholesterol was 0.5 µmol/mmol. After one month of taking ubiquinol 100 mg three times per day, plasma was rechecked in October 2006, and had more than doubled to 5.2 µg/ml with 0.5% oxidized, and C CoQ10 to cholesterol ratio had essentially doubled up to 1.1 µmol/mmol. This very encouraging improvement in plasma level in healthy individuals led us to further evaluate the reduced CoQ10 product in other populations.
It is my strong feeling that this ubiquinol product is a major breakthrough. I have carefully reviewed our experience with ubiquinol beginning last summer when we initially evaluated this product in healthy subjects. I will briefly summarize this as follows:
In September 2006, a healthy 52 years old woman on 100 mg three times per day of CoQ10 oxidized formulation in soybean oil, plasma CoQ10 level was 2.5 µg/ml with 0.7% oxidized and the ratio of CoQ10 to cholesterol was 0.5 µmol/mmol. After one month of taking ubiquinol 100 mg three times per day, plasma was rechecked in October 2006, and had more than doubled to 5.2 µg/ml with 0.5% oxidized, and C CoQ10 to cholesterol ratio had essentially doubled up to 1.1 µmol/mmol. This very encouraging improvement in plasma level in healthy individuals led us to further evaluate the reduced CoQ10 product in other populations.